Executive Summary
The May 20, 2026, filing batch reveals a market dominated by end-of-fiscal-year reporting, with 50+ companies announcing board meetings for Q4 and FY26 results. Key themes include a strong focus on capital returns, with several companies like Samvardhana Motherson, Grasim, Eris Lifesciences, and Aptech declaring or recommending dividends, signaling confidence in cash flows.
However, the data also shows significant divergence in performance, with standout growth in pharma (Lactose India, IOL Chemicals) and auto ancillaries (Samvardhana Motherson), contrasted by sharp deterioration in small-cap industrials (Jolly Plastic, Ramgopal Polytex) and a major related-party transaction at IRB Infrastructure. Insider trading activity is notably absent from the filings, but forward-looking statements point to capacity expansions at IOL Chemicals and a large debt raise at Samvardhana Motherson. The most critical development is the IRB Infrastructure deal, a ₹23,000 crore related-party arrangement that will require close monitoring for shareholder approval and execution. Overall, the digest points to a market rewarding scale and execution in large-caps while punishing weak balance sheets in smaller entities.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: M&A · Corporate action · Corporate governance · Open offer · Company update · Debt securities
Tracking the trend? Catch up on the prior India Stock Market Daily Regulatory Digest digest from May 19, 2026.
Investment Signals (12)
- Lactose (India) Ltd ↓ (BULLISH)▲
Revenue grew 24.5% YoY in Q4 and 40.3% YoY for FY26, with net profit surging 255% YoY in Q4, driven by the pharma segment. Clean audit opinion.
- Samvardhana Motherson International ↓ (BULLISH)▲
FY26 consolidated revenues hit ₹92,911 Crore, with total dividend increased to ₹0.60/share (up from ₹0.57 in FY25). Board approved up to ₹5,000 Crore NCD issuance, signaling growth capex.
- IOL Chemicals and Pharmaceuticals ↓ (BULLISH)▲
Board approved ₹22.75 Crore in new capex (Triacetin plant + Pantoprazole expansion) funded via internal accruals, indicating strong cash generation and growth visibility.
- Grasim Industries ↓ (BULLISH)▲
Recommended a ₹10/share dividend (500% on face value of ₹2) and approved a 26% stake in a 62.95 MW captive wind-solar hybrid project (₹30.6 Cr), aligning with green energy goals.
- Eris Lifesciences ↓ (BULLISH)▲
Declared an interim dividend of ₹7.21/share (721%) for FY26-27, with consolidated revenues of ₹545.48 Crore and a clean audit opinion, reflecting strong cash flows.
- Aptech Limited ↓ (BULLISH)▲
Declared an interim dividend of ₹4.5/share (45%) and received a clean audit opinion, while also seeking to reclassify a promoter to public, which could improve corporate governance.
-
Board approved material related-party arrangements with 12 SPVs valued at up to ₹23,012 Crore for O&M services, a massive revenue stream but with execution and governance risks. [NEUTRAL/BULLISH]
- Jolly Plastic Industries ↓ (BEARISH)▲
Q4 net loss of ₹27 Lakh vs profit of ₹22.26 Lakh in Q4 FY25, with expenses surging 380% YoY. Full-year net profit fell 40.1%. Cash reserves collapsed from ₹305.6 Lakh to ₹14.84 Lakh.
- Ramgopal Polytex Ltd ↓ (BEARISH)▲
FY26 net loss widened to ₹99.11 Lakh (vs ₹18.52 Lakh loss in FY25), revenue declined 26.2% YoY, and a ₹77.16 Lakh GST provision was made. Company selling its only significant investment (shares in Ramgopal Synthetics) for ₹134.9 Lakh.
- ATV Projects India ↓ (BEARISH)▲
Q4 revenue grew 13% YoY but net profit fell 19.8% YoY. Full-year revenue declined 4.1% YoY and net profit slipped 3.3% YoY. Finance costs surged 560% YoY, indicating rising debt burden.
-
Board approved raising up to ₹250 Crore via QIP/FCCBs, which could dilute existing shareholders. Also saw the resignation of the Company Secretary, though a replacement was quickly appointed. [NEUTRAL/BEARISH]
- Healthcare Global Enterprises ↓ (BULLISH)▲
Confirmed no deviation in the use of ₹424.68 Crore rights issue proceeds, with funds allocated to debt repayment (₹170 Cr) and acquisition of subsidiary stake (₹154 Cr), a positive sign of capital discipline.
Risk Flags (8)
- Jolly Plastic Industries / Financial Distress↓ [HIGH RISK]▼
Q4 net loss of ₹27 Lakh vs profit of ₹22.26 Lakh in Q4 FY25. Expenses surged 380% YoY (admin expenses to ₹20.08 Lakh from ₹2.90 Lakh). Cash and cash equivalents collapsed from ₹305.60 Lakh to ₹14.84 Lakh, a 95% decline, indicating severe liquidity stress.
- ▼
FY26 net loss widened to ₹99.11 Lakh from ₹18.52 Lakh loss in FY25. Revenue declined 26.2% YoY. A ₹77.16 Lakh GST provision was booked. Accumulated losses worsened to ₹391.91 Lakh. The company is selling its only significant asset (shares in Ramgopal Synthetics) to raise cash.
- ATV Projects India / Rising Finance Costs↓ [HIGH RISK]▼
Finance costs surged 560% YoY to ₹4.29 Lakh from ₹0.65 Lakh, while full-year revenue declined 4.1% and net profit slipped 3.3%. This combination of rising debt costs and falling profitability is a red flag for financial health.
- ▼
The board approved related-party transactions with 12 SPVs valued at up to ₹23,012 Crore (including GST). This represents a massive concentration of revenue with related entities, requiring close scrutiny of pricing and governance. Subject to shareholder approval, which could be contentious.
- Borosil Scientific / Potential Dilution↓ [MEDIUM RISK]▼
The board approved a proposal to raise up to ₹250 Crore via QIP, FCCBs, or other modes. While this could fund growth, it poses a significant dilution risk for existing shareholders, especially given the company's current market cap.
-
While consolidated revenues were strong, 59 unaudited subsidiaries reported a net loss of ₹127 Crore for the year. This indicates that parts of the group are underperforming, and the lack of audit for these entities adds an element of uncertainty.
- Shantai Industries / Open Offer Risk↓ [MEDIUM RISK]▼
The open offer at ₹21/share is for 25.60% of voting capital, which is just below the 26% minimum typically required under SEBI SAST regulations. This technicality could lead to regulatory challenges or a failed offer, creating uncertainty for minority shareholders.
- Jolly Plastic Industries / Governance Concern↓ [MEDIUM RISK]▼
The company filed two separate filings for the same results (filings #23 and #24), with the second filing revealing a much worse cash position (₹14.84 Lakh vs ₹305.60 Lakh at start of year). This inconsistency in disclosure is a governance red flag.
Opportunities (10)
- Lactose (India) Ltd / Pharma Growth Story↓ (OPPORTUNITY)◆
Revenue grew 40.3% YoY for FY26, net profit up 17.4% YoY, and Q4 net profit surged 255% YoY. The company operates in a single pharma segment with a clean audit. The pending merger with Vitanosh Ingredients could unlock further value.
- ◆
Board approved a ₹16.88 Cr Triacetin plant (6000 MTPA) and ₹5.87 Cr Pantoprazole expansion (240 to 276 MTPA), both funded via internal accruals. This signals strong management confidence and provides a clear growth catalyst for FY27.
- ◆
FY26 revenues hit ₹92,911 Crore, with total dividend increased to ₹0.60/share (5.3% YoY growth). The ₹5,000 Crore NCD issuance will fund growth without equity dilution. Trading at reasonable valuations for a global auto ancillary leader.
- Grasim Industries / Green Energy Play↓ (OPPORTUNITY)◆
The acquisition of a 26% stake in a 62.95 MW captive wind-solar hybrid project for ₹30.6 Crore aligns with India's renewable energy push. This will help optimize energy costs for its core businesses and is a positive ESG signal.
- IRB Infrastructure Developers / Revenue Visibility↓ (OPPORTUNITY)◆
The ₹23,012 Crore related-party O&M contracts provide massive long-term revenue visibility. If approved, this could significantly boost earnings. The 4th interim dividend (₹0.05/share) and clean audit are additional positives.
- Eris Lifesciences / High Dividend Yield↓ (OPPORTUNITY)◆
Declared an interim dividend of ₹7.21/share (721%), one of the highest in the batch. With consolidated revenues of ₹545.48 Crore and a clean audit, the company offers a strong yield play in the pharma space.
- Aptech Limited / Governance Improvement↓ (OPPORTUNITY)◆
The reclassification of Mr. Utpal Sheth from 'Promoter Group' to 'Public' category, if approved, will improve corporate governance and potentially lead to a re-rating. The interim dividend of ₹4.5/share is an additional positive.
- NGL Fine-Chem Limited / Dividend Catalyst↓ (OPPORTUNITY)◆
Board meeting on May 21 to consider a final dividend for FY26. The company has a history of consistent dividends, and the announcement could act as a near-term catalyst.
- ◆
The company confirmed no deviation in the use of ₹424.68 Crore rights issue proceeds, with ₹170 Cr used for debt repayment and ₹154 Cr for acquiring a subsidiary stake. This disciplined capital allocation is a positive signal for long-term investors.
- Star Cement / Earnings Call Catalyst↓ (OPPORTUNITY)◆
Conference call on May 26 with senior management (Deputy MD and CFO) to discuss Q4 and FY26 results. This could provide positive surprises or guidance, especially given the strong demand in the cement sector.
Sector Themes (6)
- Pharma Sector Outperformance◆
Lactose India (revenue +40.3% YoY, net profit +17.4% YoY) and IOL Chemicals (new capex, clean audit) show strong performance. Eris Lifesciences also reported clean audits and high dividends. This contrasts with the broader market and suggests the pharma sector is benefiting from strong domestic demand and export opportunities.
- Small-Cap Distress Signal◆
Jolly Plastic Industries (net loss, cash collapse) and Ramgopal Polytex (widening losses, asset sales) highlight a growing divergence in the small-cap space. Companies with weak balance sheets are being punished, while those with strong cash flows (Lactose, IOL) are investing. This suggests a 'flight to quality' within small-caps.
- Infrastructure & Capex Cycle◆
IRB Infrastructure (₹23,012 Cr related-party deals), Grasim (₹30.6 Cr green energy investment), and IOL Chemicals (₹22.75 Cr capex) all point to a robust capex cycle. This is a positive sign for the broader economy and for companies in the infrastructure and capital goods value chain.
- Dividend Payout Trend◆
Multiple companies declared or recommended dividends: Samvardhana Motherson (₹0.60/share, +5.3% YoY), Grasim (₹10/share), Eris Lifesciences (₹7.21/share), Aptech (₹4.5/share), and IRB Infrastructure (₹0.05/share). This indicates strong corporate cash flows and a shareholder-friendly approach, particularly in large-caps.
- Rising Finance Costs Impact◆
ATV Projects India saw finance costs surge 560% YoY, while Jolly Plastic's expenses soared 380% YoY. This theme of rising input and financing costs is squeezing margins for smaller, debt-laden companies, even as larger players with better access to capital (Samvardhana Motherson, Grasim) continue to invest.
- Corporate Governance in Focus◆
Several filings highlight governance actions: Aptech's promoter reclassification, Borosil Scientific's CS resignation and quick replacement, and the detailed related-party disclosures from IRB Infrastructure. This suggests companies are proactively managing governance ahead of potential regulatory scrutiny.
Watch List (8)
-
The ₹23,012 Crore related-party transaction requires shareholder approval. Watch for the voting outcome and any dissent from institutional investors. Record date for dividend is May 26, 2026.
-
The ₹5,000 Crore NCD issuance on a private placement basis will be a key event to monitor for terms (coupon rate, tenure). The AGM is scheduled for July 30, 2026, with a record date for the final dividend on July 14, 2026.
-
The proposal to raise up to ₹250 Crore via QIP/FCCBs will require shareholder approval. Watch for the mode of fundraising (dilutive vs non-dilutive) and the pricing, which will impact existing shareholders.
-
The proposed merger with Vitanosh Ingredients Private Limited remains pending regulatory approvals. Any update on this front could be a significant catalyst. Watch for filings related to NCLT or other regulatory bodies.
-
The open offer at ₹21/share runs from May 26 to June 9, 2026. Watch for the final acceptance level and whether the offer succeeds given it is just below the 26% threshold. Any competing offer or regulatory intervention would be material.
-
The board meets on May 21, 2026, to consider a final dividend. The outcome will be a near-term catalyst for the stock. Watch for the dividend amount and any commentary on future prospects.
-
With cash reserves collapsing to ₹14.84 Lakh, the company's ability to continue as a going concern is a key risk. Watch for any announcements regarding fundraising, asset sales, or restructuring.
-
The company is participating in three major investor conferences between May 29 and June 8, 2026 (TRINITY INDIA, Nomura Singapore, ICICI Securities). Watch for any management commentary or presentations that could provide insights into demand trends and guidance.
Filing Analyses
(50)
20-05-2026
Triveni Engineering & Industries Limited has made effective the Composite Scheme of Arrangement involving itself, Sir Shadi Lal Enterprises Limited (SSEL), and Triveni Power Transmission Limited (TPTL), following NCLT approval and filing with the Registrar of Companies on May 19, 2026. This marks the operational completion of the merger/arrangement process.
- · The Scheme was sanctioned by the Hon'ble National Company Law Tribunal Allahabad Bench via Orders dated May 7, 2026 and May 18, 2026.
- · The effective date of the Scheme is May 19, 2026, coinciding with the filing of NCLT Orders (Form INC 28) with the Registrar of Companies around 6:45 p.m.
- · The Scheme involves Sections 230 to 232 of the Companies Act, 2013.
20-05-2026
Healthcare Global Enterprises Limited filed a statement confirming no deviation or variation in the utilisation of funds raised through its Rights Issue for the quarter ended March 31, 2026. The company raised ₹424,68,17,792 (₹424.68 Crore) via allotment on March 27, 2026, with proceeds allocated for debt repayment (₹170.00 Cr), acquisition of additional stake in a subsidiary (₹154.04 Cr), general corporate purposes (₹95.57 Cr), and issue expenses (₹5.07 Cr). The Audit Committee reviewed the statement and had no comments, and the monitoring agency is CARE Ratings Limited.
- · Funds were raised through a Rights Issue with allotment date of March 27, 2026.
- · The monitoring agency for the issue is CARE Ratings Limited.
- · The Audit Committee reviewed the statement and had no comments.
- · No deviation or variation was reported for any of the four stated objects: debt repayment, acquisition, general corporate purposes, and issue expenses.
20-05-2026
Priya Limited has informed BSE that a Board Meeting will be held on May 28, 2026, to consider and approve the audited financial results for the quarter and year ended March 31, 2026. The trading window for insiders has been closed from April 1, 2026, and will reopen 48 hours after the results are made public on June 1, 2026.
- · Board meeting scheduled for May 28, 2026 at the registered office in Mumbai.
- · Trading window closed from April 1, 2026 until 48 hours after results announcement (expected June 1, 2026).
- · Scrip code: 524580
- · CIN: L99999MH1986PLC040713
20-05-2026
Radhe Dhokla Private Limited and four individual acquirers (Pandav Dishant Kanubhai, Nikunj Vijaybhai Prajapati, Pandav Jinesh Kanaiyalal, Pandav Pradipkumar Vijaybhai) have launched an open offer to acquire up to 19,20,000 equity shares (25.60% of voting capital) of Shantai Industries Limited at ₹21 per share, aggregating ₹4,03,20,000. The offer opens on May 26, 2026 and closes on June 9, 2026, and is not conditional on any minimum acceptance level. However, the offer size is restricted to the public shareholding of 25.60%, falling just short of the 26% minimum typically required under SEBI (SAST) Regulations.
- · The open offer is made under Regulations 3(1) and 4 of SEBI (SAST) Regulations, 2011 for substantial acquisition of shares/voting rights accompanied with change in control.
- · The offer is not conditional upon any minimum level of acceptance (Regulation 19).
- · No competing offer exists as of the date of the Letter of Offer.
- · The marketable lot for the equity shares is 1 (one).
- · Acquirers reserve the right to revise the offer price and/or size upwards prior to the last working day before the tendering period.
- · The identified date for determining public shareholders is May 12, 2026.
- · The target company's CIN shows incorporation year 1988, but the actual incorporation date is April 9, 1985; a rectification application was rejected by ROC on February 25, 2026.
- · The offer size is restricted to 19,20,000 shares (25.60%) because that is the entire public shareholding, falling short of the 26% minimum under Regulation 7.
20-05-2026
21st Century Management Services Limited has published a notice for a Board Meeting to be held on May 27, 2026, to consider and approve the standalone and consolidated financial results for the quarter and year ended March 31, 2026, along with other business matters. The notice was published in Trinity Mirror (English) and Makkal Kural (Tamil) on May 19, 2026, as required under SEBI Listing Regulations. The filing also contains numerous unrelated legal notices and name change announcements from various individuals and entities, which are not material to the company's operations.
- · The Board Meeting is scheduled for May 27, 2026, at 4:00 PM.
- · The agenda includes consideration of financial results for the quarter and year ended March 31, 2026, as per Ind AS.
- · The notice was published in Trinity Mirror (English) and Makkal Kural (Tamil) newspapers on May 19, 2026.
- · The filing includes a large number of unrelated legal notices (e.g., name changes, enrollment notices, court cases) that are not related to the company's business.
20-05-2026
Satyam Silk Mills Ltd has informed BSE that a Board Meeting is scheduled for May 29, 2026, to consider and approve the audited standalone financial results for the quarter and year ended March 31, 2026. The trading window for insiders, which closed from April 1, 2026, will reopen 48 hours after the results are declared. No financial figures or performance comparisons are provided in this filing.
- · Board meeting date: May 29, 2026
- · Trading window closure period: April 1, 2026 until 48 hours after results declaration
- · Results to be considered: Audited standalone financial results for Q4 and FY ended March 31, 2026
20-05-2026
Vistar Amar Limited has informed BSE that its Board of Directors will meet on May 28, 2026, to consider and approve the audited financial results for the quarter and year ended March 31, 2026. The trading window for designated persons and their immediate relatives remains closed from April 1, 2026, to May 30, 2026, as per insider trading regulations.
- · Board meeting scheduled for May 28, 2026 at 5:00 PM via video conferencing
- · Agenda includes approval of audited financial results for Q4 and FY ended March 31, 2026
- · Trading window closure period: April 1, 2026 to May 30, 2026
- · Intimation made under Regulation 29 of SEBI Listing Regulations
20-05-2026
Pee Cee Cosma Sope Ltd. has informed BSE Ltd. that a Board Meeting will be held on May 29, 2026, to consider and approve the audited financial results (standalone and consolidated) for the quarter and year ended March 31, 2026, and to recommend a dividend on equity shares for FY 2025-2026, if any. The trading window for designated persons and their relatives has been closed from April 1, 2026, until 48 hours after the results announcement.
- · Board meeting scheduled for Friday, May 29, 2026.
- · Agenda includes approval of audited financial results (standalone and consolidated) for Q4 and FY ended March 31, 2026.
- · Dividend recommendation for FY 2025-2026 will be considered, subject to shareholder approval at the AGM.
- · Trading window closed from April 1, 2026, until 48 hours after the results announcement to stock exchanges.
- · The information is also available on the company's website (www.peeceecosma.com) and BSE India website.
20-05-2026
Lactose (India) Ltd. reported audited financial results for Q4 and FY ended March 31, 2026, with revenue from operations rising 24.5% YoY to ₹4,576.61 Lakhs in Q4 and 40.3% YoY to ₹16,329.01 Lakhs for the full year. Net profit after tax grew 255% YoY to ₹187.69 Lakhs in Q4 and 17.4% YoY to ₹606.28 Lakhs for FY26. However, other income declined 43.1% YoY in Q4 and 26.3% YoY for the full year, and the company's proposed merger with Vitanosh Ingredients Private Limited remains pending regulatory approvals.
- · Statutory auditors DMKH & Co. issued an unmodified (clean) audit opinion for FY26 financial results.
- · Board meeting commenced at 12:00 noon and concluded at 2:00 PM on May 20, 2026.
- · The company operates in a single reportable business segment: Pharmaceuticals.
- · The Scheme of Merger with Vitanosh Ingredients Private Limited was approved by shareholders at an EGM on March 28, 2026, but is pending final approvals from SEBI and NCLT.
- · On December 5, 2024, the company issued 15,00,000 convertible warrants at ₹174 each; 25% (₹652.50 Lakhs) received upfront; balance due within 18 months.
- · Government of India notified four new Labour Codes; draft rules published on December 30, 2025; financial impact assessment is pending.
20-05-2026
ATV Projects India Ltd reported its audited standalone financial results for the quarter and year ended March 31, 2026. For Q4 FY26, revenue grew 13.0% sequentially and 13.0% YoY to ₹2,009.84 Lakh, but net profit fell 19.8% YoY to ₹206.23 Lakh, and for the full year FY26, revenue declined 4.1% YoY to ₹6,765.31 Lakh while net profit slipped 3.3% YoY to ₹715.50 Lakh, reflecting a mixed performance. The Board also approved the appointment of internal auditors, related party transactions, and set the AGM for August 12, 2026.
- · Total comprehensive income for FY26 stood at ₹715.50 Lakh, down from ₹740.12 Lakh in FY25 (YoY decline of 3.3%).
- · Finance costs for FY26 surged to ₹4.29 Lakh from ₹0.65 Lakh in FY25, a 560% increase.
- · Total assets as of March 31, 2026 stood at ₹26,980.39 Lakh, up from ₹25,929.68 Lakh as of March 31, 2025 (increase of 4.1%).
- · Cash and cash equivalents improved to ₹665.19 Lakh as of March 31, 2026 from ₹143.23 Lakh as of March 31, 2025.
- · Long-term borrowings (non-current) reduced to ₹3,643.00 Lakh from ₹4,267.42 Lakh (YoY decrease of 14.6%).
- · Other equity (reserves) increased to ₹16,056.11 Lakh from ₹15,340.61 Lakh (YoY increase of 4.7%).
- · Inventories rose sharply to ₹2,895.45 Lakh from ₹2,096.45 Lakh (YoY increase of 38.1%).
- · Trade and other receivables decreased to ₹1,052.67 Lakh from ₹1,317.50 Lakh (YoY decline of 20.1%).
- · Auditors issued an unmodified (clean) opinion on the financial statements.
- · Annual General Meeting fixed for August 12, 2026; register of members closure from August 6 to August 12, 2026.
- · Related party transactions include a balance payable to Seftech Phosphate Private Limited of ₹693.88 Lakh (opening), closing debit balance of ₹3,294.16 Lakh (net payable by the company).
20-05-2026
Star Cement Limited has announced a conference call for investors and analysts on May 26, 2026, at 4:00 PM IST to discuss the audited financial results for Q4 and the full year ended March 31, 2026. The call will be hosted by PhillipCapital and will feature senior management including Deputy Managing Director Tushar Bhajanka and CFO Manoj Agarwal. No financial results or performance data have been disclosed in this filing.
- · Conference call scheduled for Tuesday, 26th May 2026 at 04:00 PM IST
- · Dial-in primary number: +91 22 6280 1143; secondary: +91 22 7115 8044
- · Toll-free numbers available for USA, UK, Singapore, and Hong Kong
- · Pre-registration available via a provided link
- · Call proceedings will be recorded and transcript will be shared with stock exchanges
20-05-2026
Kotia Enterprises Limited has informed the stock exchanges that a Board Meeting will be held on Saturday, May 30, 2026, to consider and adopt the standalone audited financial results for the quarter and year ended March 31, 2026. The trading window for designated persons and their immediate relatives will remain closed until 48 hours after the results are declared.
- · Board meeting scheduled for Saturday, May 30, 2026.
- · Agenda includes consideration and adoption of standalone audited financial results for Q4 and FY ended March 31, 2026.
- · Trading window closure for designated persons and their immediate relatives remains in effect until 48 hours after the results declaration.
20-05-2026
IRB Infrastructure Developers Ltd board approved audited financial results for Q4 and FY ended March 31, 2026, with an unmodified audit opinion. The board declared a 4th interim dividend of 5% (Re.0.05 per share) for FY 2025-26, record date May 26, 2026, payment by June 18, 2026. Additionally, in-principle approval was granted for material related party arrangements with 12 project SPVs for O&M and project management services, valued up to INR 19,501.90 crore (plus GST, total approx. INR 23,012.24 crore), subject to shareholder and regulatory approvals.
- · Audited financial results for quarter and year ended March 31, 2026, received unmodified audit opinion.
- · 4th interim dividend of 5% (Re.0.05 per equity share of face value Re.1 each) declared for FY 2025-26.
- · Record date for dividend: May 26, 2026; payment on or before June 18, 2026.
- · In-principle approval for material related party arrangements with 12 project SPVs for O&M and project management services.
- · Aggregate estimated value of arrangements: up to INR 19,501.90 crore (plus GST, total approx. INR 23,012.24 crore).
- · Arrangements subject to shareholder approval, applicable approvals, and execution of amendments.
- · Board meeting started at 12:30 pm and concluded at 2:05 pm.
20-05-2026
Indergiri Finance Limited has informed BSE that its Board of Directors will meet on May 28, 2026, to consider and approve the audited standalone financial results for the quarter and year ended March 31, 2026. The trading window for dealing in the company's securities has been closed from April 1, 2026, and will remain closed until 48 hours after the results announcement, i.e., up to May 30, 2026.
- · Board meeting scheduled for May 28, 2026 at Unit No. 908, A Wing, Rustomjee Central Park, Andheri–Kurla Road, Chakala, Andheri East, Mumbai – 400093.
- · Trading window closed from April 1, 2026 and will reopen after 48 hours of the results announcement, i.e., up to May 30, 2026.
- · Filing made under Regulation 29(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
20-05-2026
Crizac Limited has informed the stock exchanges that a Board Meeting is scheduled for May 25, 2026, to consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The trading window for insiders remains closed until 48 hours after the results are declared. No financial figures or performance comparisons are provided in this filing.
- · Board meeting scheduled for Monday, May 25, 2026.
- · Agenda includes approval of audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026.
- · Trading window for insiders has been closed since March 26, 2026, and will remain closed until 48 hours after the results are declared.
- · Contact details: (033) 3544-1515, info@crizac.com.
20-05-2026
Kerala Ayurveda Limited has informed the Bombay Stock Exchange that a Board Meeting is scheduled for May 25, 2026, to consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The trading window for designated persons has been closed since March 31, 2026, and will reopen 48 hours after the results are made public. No financial figures or performance comparisons are provided in this filing.
- · Board meeting date: May 25, 2026
- · Trading window closed from March 31, 2026 until 48 hours after results are made public
- · Results to be considered: audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026
- · Company is ISO 9001:2015 certified
- · Registered office in Ernakulam, Kerala; Corporate office in Bengaluru
20-05-2026
Khadim India Limited's Board approved the audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026, with an unmodified audit opinion from M/s Ray & Ray. The Board also approved the reappointment of M/s Ray & Ray as statutory auditors for a second term of five years, subject to shareholder approval. The filing itself does not contain the actual financial figures, only the audit reports and board outcomes.
- · Audit opinion is unmodified (clean) for both standalone and consolidated results.
- · Statutory auditors Ray & Ray (FRN 301072E) reappointed for a second term of 5 years from conclusion of 45th AGM to 50th AGM (FY 2031-32).
- · Subsidiary: Khadim Shoe Bangladesh Limited (100% held foreign subsidiary) is included in consolidated results; its financials were audited by other auditors.
- · The financial results for the quarter ended March 31, 2026 are balancing figures between the audited full year and published unaudited nine-month figures.
- · Board meeting held May 20, 2026; commenced 1:30 PM and concluded at approximately 2:10 PM.
20-05-2026
IRB Infrastructure Developers Limited reported audited consolidated and standalone financial results for Q4 and FY ended March 31, 2026, with an unmodified audit opinion. The Board declared a 4th interim dividend of 5% (₹0.05 per share) for FY2025-26, with record date May 26, 2026, and payment by June 18, 2026. Additionally, the Board granted in-principle approval for material related-party arrangements with 12 project SPVs of IRB Infrastructure Trust for O&M and project management services, valued at up to ₹19,501.90 crore (plus GST, totaling ~₹23,012.24 crore), subject to shareholder and regulatory approvals.
- · Auditor's report on both standalone and consolidated financial results is unmodified (clean opinion).
- · Record date for the 4th interim dividend is May 26, 2026; payment on or before June 18, 2026.
- · The proposed related-party arrangements are subject to shareholder approval, receipt of all applicable approvals, and execution of amendments to project implementation agreements.
- · The arrangements are on an arm's-length basis and in the ordinary course of business.
- · Board meeting started at 12:30 PM and concluded at 2:05 PM on May 20, 2026.
20-05-2026
Samvardhana Motherson International Limited approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026, and recommended a final dividend of INR 0.25 per share, bringing total FY dividend to INR 0.60 per share (up from INR 0.57 in FY25). The consolidated results include audited figures from 121 subsidiaries (total assets Rs 1,48,950 Crore, total revenues Rs 92,911 Crore for the year) and unaudited figures from 59 subsidiaries (total revenues Rs 2,244 Crore for the year). The statutory auditors issued an unmodified opinion on both standalone and consolidated results.
- · The Board meeting commenced at 1000 Hours (IST) and concluded at 1420 Hours (IST) on May 20, 2026.
- · The record date for the final dividend is July 14, 2026, and the AGM is scheduled for July 30, 2026.
- · The statutory auditors issued an unmodified opinion on both standalone and consolidated financial results for FY ended March 31, 2026.
- · The 59 unaudited subsidiaries reported a net loss after tax of Rs. 127 Crore for the year ended March 31, 2026, and a net profit of Rs. 58 Crore for the quarter.
- · The 59 unaudited subsidiaries reported total comprehensive expense of Rs. 130 Crore for the year ended March 31, 2026.
20-05-2026
Infibeam Avenues Limited (now AvenuesAI Limited) announced a conference call on May 29, 2026 at 4:30 PM IST to discuss audited financial results for Q4 and FY ended March 31, 2026. The call will feature Chairman Vishal Mehta, MD & CEO Vishwas Patel, CFO Sunil Bhagat, and other senior management.
- · Company name changed to AvenuesAI Limited (formerly Infibeam Avenues Limited).
- · Conference call scheduled for May 29, 2026 at 4:30 PM IST.
- · Dial-in numbers: +91 22 6280 1557 / +91 22 7115 8383.
- · Pre-registration available via Diamond Pass to avoid wait time.
20-05-2026
TCI Industries Ltd. held a Board Meeting on May 19, 2026, approving audited financial results for Q4 and FY ended March 31, 2026 (results enclosed but not detailed in filing). Key management changes include the resignation of Whole-time Director Sunil K. Warerkar (effective June 30, 2026) and the appointment of Samir Thete as President. The board also re-appointed Gokhale & Sathe as internal auditor for FY 2026-27. No financial figures were provided in this filing letter, so directional performance cannot be assessed.
- · The Board Meeting commenced at 15:35 hours and concluded at 17:05 hours on May 19, 2026.
- · Mr. Sunil K. Warerkar resigned due to personal reasons, effective from the closing of office hours on June 30, 2026.
- · Mr. Samir Thete holds a B.Sc. degree and a Post Graduate Diploma in Business Management and Human Resource Management with 25+ years of experience.
- · The re-appointed internal auditor, Gokhale & Sathe, specializes in internal and process audits, tax advisory, and business consulting for the corporate and BFSI sectors.
- · All applicable SEBI disclosure items (deviation on proceeds, default on loans, related party transactions, audit qualification impact) were marked 'Not Applicable'.
- · The filing does not contain any financial figures; the actual financial results are provided in an enclosed annexure not included in the submission.
20-05-2026
Reliance Industries Limited disclosed that its associate company BAM DLR Kolkata Private Limited, a non-operating entity, has been voluntarily struck off by the Register of Companies effective May 19, 2026. As a result, BAM DLR has ceased to be an associate of Reliance Industries. This is a routine corporate action with no financial impact on Reliance.
- · BAM DLR Kolkata Private Limited was a non-operating associate company of Reliance Industries.
- · The voluntary strike-off was approved by BAM DLR's board and became effective on May 19, 2026.
- · The disclosure was made under Regulation 30 of SEBI (LODR) Regulations, 2015.
20-05-2026
Jolly Plastic Industries Ltd. reported audited financial results for Q4 and FY ended March 31, 2026. Revenue from operations for Q4 FY26 was ₹6.77 lakh, down from ₹7.24 lakh in Q3 FY25 and ₹2.70 lakh in Q4 FY25. The company posted a net loss of ₹27.00 lakh for Q4 FY26, compared to a profit of ₹0.40 lakh in Q3 FY25 and a profit of ₹22.26 lakh in Q4 FY25. For the full year, net profit declined to ₹1.06 lakh from ₹1.77 lakh in FY25.
- · Total income for Q4 FY26 was ₹6.81 lakh, down from ₹9.42 lakh in Q3 FY25 and ₹29.80 lakh in Q4 FY25.
- · Total expenses for Q4 FY26 were ₹33.41 lakh, up from ₹9.01 lakh in Q3 FY25 and ₹6.95 lakh in Q4 FY25.
- · Total assets as at March 31, 2026 were ₹689.43 lakh, compared to ₹687.64 lakh as at March 31, 2025.
- · Cash and cash equivalents declined sharply from ₹305.60 lakh as at March 31, 2025 to ₹14.84 lakh as at March 31, 2026.
- · The company confirmed no deviation in use of IPO proceeds.
- · Auditor's report was unmodified.
20-05-2026
Jolly Plastic Industries Ltd. reported audited financial results for Q4 and FY ended March 31, 2026, with full-year revenue from operations increasing to ₹22.60 Lakh from ₹17.02 Lakh in FY2025, a 32.8% growth. However, the company posted a net loss of ₹27.00 Lakh for Q4 FY2026, a sharp decline compared to a profit of ₹22.26 Lakh in Q4 FY2025, and full-year net profit fell 40.1% to ₹1.06 Lakh from ₹1.77 Lakh. Cash and cash equivalents plummeted to ₹14.84 Lakh from ₹305.60 Lakh at the start of the year, primarily due to a significant outflow for loans and advances (₹638.07 Lakh in non-current loans and advances).
- · Total income for Q4 FY2026 fell to ₹6.81 Lakh from ₹29.80 Lakh in Q4 FY2025.
- · Total expenses for Q4 FY2026 surged to ₹33.41 Lakh from ₹6.95 Lakh in Q4 FY2025, driven by a sharp rise in administration and other expenses (₹20.08 Lakh vs ₹2.90 Lakh) and employee benefits expense (₹6.76 Lakh vs ₹1.38 Lakh).
- · Other income for the full year dropped to ₹24.49 Lakh from ₹44.41 Lakh in FY2025.
- · Non-current loans and advances rose sharply to ₹638.07 Lakh (FY2026) from ₹343.53 Lakh (FY2025).
- · Total assets were nearly flat at ₹689.43 Lakh (FY2026) vs ₹687.64 Lakh (FY2025).
- · Current liabilities increased to ₹0.93 Lakh from ₹0.20 Lakh.
- · Earnings per share (basic) for FY2026: ₹0.0159, down from ₹0.0265 in FY2025.
- · No dividend or exceptional items were reported.
- · The company confirmed no deviation in use of IPO proceeds.
20-05-2026
Nouveau Global Ventures Limited has informed BSE that a Board Meeting is scheduled for May 26, 2026, to consider and approve the audited financial results for the quarter and financial year ended March 31, 2026. The trading window for designated persons remains closed until 48 hours after the results are declared. No financial figures or performance comparisons are provided in this prior intimation.
- · Board Meeting date: May 26, 2026
- · Agenda includes approval of audited financial results for Q4 and FY ended March 31, 2026
- · Trading window closure continues until 48 hours after results declaration
- · Reference to Regulation 29 of SEBI LODR Regulations, 2015
20-05-2026
Ramgopal Polytex Ltd reported a significantly widened net loss of ₹99.11 Lakh for FY2026 vs ₹18.52 Lakh loss in FY2025, with revenues declining 26.2% YoY to ₹109.36 Lakh. The Board approved the sale of its 1,90,000 equity shares in Ramgopal Synthetics Ltd for a lump sum consideration of ₹1,34,90,000 and appointed M/s. Ravi Seth & Co. as Internal Auditor for FY2026-27. The auditors issued an unmodified (clean) opinion on the annual audited results.
- · The statutory auditors M/s. Rungta Agarwal and Associates issued an unmodified (clean) opinion on the audited financial results.
- · The company's other equity (accumulated losses) worsened to ₹(391.91) Lakh as of March 31, 2026 compared to ₹(319.78) Lakh in the prior year, a decline of 22.6%.
- · A provision of ₹77.16 Lakh was made for Goods & Service Tax credits during FY2026, contributing significantly to the increased loss.
- · The sale of 1,90,000 shares in Ramgopal Synthetics Ltd was executed at ₹71 per share, with expected completion by May 31, 2026.
- · The Board meeting commenced at 1:00 PM and concluded at 2:15 PM on May 20, 2026.
- · Mr. Ravi Seth & Co. has been appointed as Internal Auditor for FY2026-27 effective May 20, 2026.
20-05-2026
Jagatjit Industries Ltd. has informed BSE that a Board meeting is scheduled for May 28, 2026, to consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The trading window for designated persons will remain closed until May 30, 2026, in compliance with insider trading regulations.
- · Board meeting date: May 28, 2026
- · Trading window closure period: from May 20, 2026 (filing date) until May 30, 2026
- · Financial results to be considered: audited standalone and consolidated for Q4 and FY ended March 31, 2026
- · Previous intimation letter referenced: dated March 24, 2026
20-05-2026
Avonmore Capital & Management Services Limited has informed the stock exchanges that a Board Meeting will be held on May 26, 2026, to consider and approve the audited financial results (standalone and consolidated) for the quarter and financial year ended March 31, 2026, as well as the annual accounts for FY 2025-26. No financial figures or performance data are provided in this filing.
- · Board Meeting scheduled for May 26, 2026
- · Agenda includes approval of audited financial results (standalone and consolidated) for Q4 and FY ended March 31, 2026
- · Agenda also includes taking on record the annual accounts for FY 2025-26
- · Notice is available on the company's website at www.avonmorecapital.in
20-05-2026
Grasim Industries' Board approved audited standalone and consolidated financial results for FY ended March 31, 2026, and recommended a dividend of ₹10 per equity share (500% on face value of ₹2). The Board also approved the appointment of Deloitte Haskins & Sells as Joint Statutory Auditor for five years, replacing BSR & Co. LLP. The auditors issued an unmodified opinion on the financial results.
- · The Board meeting commenced at 12:15 p.m. IST and concluded at 2:31 p.m. IST on May 20, 2026.
- · The dividend of ₹10 per equity share is subject to shareholder approval at the ensuing Annual General Meeting.
- · Deloitte Haskins & Sells will serve as Joint Statutory Auditor for five years from the 79th AGM to the 84th AGM, replacing BSR & Co. LLP whose second term ends at the 79th AGM.
- · KKC & Associates LLP continues as Joint Statutory Auditor.
- · The auditors issued an unmodified opinion on both standalone and consolidated financial results.
- · The standalone financial results include the financials of Grasim Employees' Trust (total assets ₹429.45 Cr, net profit ₹1.28 Cr, net cash outflow ₹0.07 Cr) and four joint operations (total assets ₹30.39 Cr, net loss ₹0.02 Cr, net cash inflow ₹0.22 Cr).
20-05-2026
Samvardhana Motherson International Limited's Board of Directors has given in-principle approval for the issuance of rated, listed, unsecured, redeemable Non-Convertible Debentures (NCDs) of face value INR 1,00,000 each, aggregating up to INR 5,000,00,00,000 (Rupees Five Thousand Crores only), on a private placement basis in one or more series/tranches. The NCDs will be listed on BSE Limited and/or National Stock Exchange of India Limited. Key terms such as tenure, coupon rate, and redemption schedule will be decided by delegated authorized persons or a committee of directors.
- · The Board meeting commenced at 1000 Hours (IST) and concluded at 1420 Hours (IST) on May 20, 2026.
- · The NCDs are unsecured (no charge/security over assets).
- · The issuance is on a private placement basis to eligible investors.
- · Specific terms (tenure, coupon, redemption) are to be decided by delegated authorized persons/committee.
20-05-2026
Ramgopal Polytex Ltd reported a net loss of ₹99.11 Lakhs for FY2026, widening sharply from a loss of ₹18.52 Lakhs in FY2025, driven by a 26% decline in revenue from operations to ₹109.36 Lakhs and a provision for GST credits of ₹77.16 Lakhs. The Board approved the sale of its 1,90,000 equity shares in Ramgopal Synthetics Limited for a lump sum consideration of ₹1,34,90,000 (₹134.90 Lakhs) to Mrs. Minal Nipoon Agarwal jointly with Mr. Nipoon G. Agarwal, and appointed Mr. Ravi Seth as Internal Auditor for FY2026-27.
- · The Board meeting commenced at 1:00 PM and concluded by 2:15 PM on May 20, 2026.
- · The statutory auditors issued an unmodified (clean) opinion on the annual audited standalone financial results for FY2026.
- · The sale of 1,90,000 shares in Ramgopal Synthetics Ltd is expected to be completed by May 31, 2026.
- · The sale price per share is ₹71, based on a valuation report.
- · The buyer is not related to the promoter/promoter group of Ramgopal Polytex Ltd.
- · The company's other equity (accumulated losses) worsened from (₹319.78 Lakhs) to (₹391.91 Lakhs) as of March 31, 2026.
- · Total liabilities increased from ₹55.00 Lakhs to ₹62.41 Lakhs year-on-year.
- · Cash flow from operations was negative at (₹60.28 Lakhs) for FY2026, compared to (₹35.61 Lakhs) in FY2025.
- · The company had no separate reportable segments as per IND AS 108.
20-05-2026
IOL Chemicals and Pharmaceuticals announced audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026, with an unmodified audit opinion. The board also approved installation of a Triacetin plant (6000 MTPA, ₹16.88 Cr capex) and expansion of Pantoprazole capacity from 240 to 276 MTPA (₹5.87 Cr capex), both funded via internal accruals. The 39th AGM is scheduled for September 2, 2026.
- · Audited financial results received unmodified opinion from statutory auditors M/s. Ashwani & Associates.
- · 39th AGM to be held on September 2, 2026 via VC/OAVM; register closure from August 27 to September 2, 2026.
- · Triacetin plant will be set up at Barnala in phases; Phase I capacity 6000 MTPA.
- · Pantoprazole capacity expansion from 240 MTPA to 276 MTPA (addition of 36 MTPA).
- · Existing Pantoprazole capacity utilization is 100%.
20-05-2026
Northern Arc Capital Limited has informed the stock exchanges that it will participate in the Ambit Conference on May 25, 2026, for group and one-on-one meetings with analysts and institutional investors. The meetings will be held physically from 9:00 AM to 3:00 PM. The company has clarified that no unpublished price-sensitive information will be shared during these interactions.
- · The meeting is scheduled for Monday, May 25, 2026, from 9:00 AM to 3:00 PM.
- · The mode of the meeting is physical.
- · The schedule is subject to change due to exigencies on the part of analysts, investors, or the company.
- · The company will refer only to publicly available documents during discussions.
20-05-2026
Samvardhana Motherson International Limited reported audited consolidated financial results for Q4 and FY ended March 31, 2026, with total revenues of Rs 92,911 Crore for the year and Rs 25,032 Crore for the quarter. The Board recommended a final dividend of INR 0.25 per share, bringing the total dividend for FY 2025-26 to INR 0.60 per share, up from INR 0.57 per share in FY 2024-25. However, the filing also reveals that 59 unaudited subsidiaries reported a net loss of Rs. 127 Crore for the year, indicating mixed performance across the group.
- · The Board meeting commenced at 1000 Hours (IST) and concluded at 1420 Hours (IST) on May 20, 2026.
- · The record date for the final dividend is July 14, 2026.
- · The Annual General Meeting is scheduled for July 30, 2026.
- · The statutory auditors issued an unmodified opinion on the audited financial results.
- · The filing includes 121 audited subsidiaries and 59 unaudited subsidiaries, with the unaudited ones reporting a net loss of Rs. 127 Crore for the year.
20-05-2026
Prudential Sugar Corporation Limited informed stock exchanges that a Board Meeting will be held on May 30, 2026, to consider and adopt the audited standalone and consolidated financial statements for Q4 and the full year ended March 31, 2026, along with the statutory auditors' report. The meeting will be held at 02:00 PM at the registered office in Hyderabad. As part of standard compliance, the trading window for insiders has been closed since April 1, 2026 and will remain closed until 48 hours after the meeting concludes.
- · Filing reference number: PSCL/SE/2026-27/May
- · Filing date is May 20, 2026 (but the letter is dated May 20, 2025 - appears to be a typographic error)
- · Meeting date: Saturday, May 30, 2026 at 02:00 PM
- · Trading window closed from April 1, 2026 until 48 hours after Board Meeting conclusion
- · Scrip codes: 500342 (BSE), PRUDMOULI (NSE), 026037 (Calcutta Stock Exchange)
- · CIN: L15432TG1990PLC032731
20-05-2026
IOL Chemicals and Pharmaceuticals announced audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026, with an unmodified audit opinion. The board also approved installation of a new Triacetin plant (6000 MTPA, ₹16.88 Cr capex) and expansion of Pantoprazole capacity from 240 to 276 MTPA (₹5.87 Cr capex), both funded via internal accruals. The 39th AGM is scheduled for September 2, 2026 via video conferencing.
- · Audited financial results received unmodified opinion from statutory auditors M/s. Ashwani & Associates.
- · 39th AGM to be held on 2nd September 2026 via VC/OAVM; register closure from 27th August to 2nd September 2026.
- · Triacetin plant capex of ₹16.88 Cr fully funded through internal accruals.
- · Pantoprazole capacity expansion capex of ₹5.87 Cr fully funded through internal accruals.
- · Existing Pantoprazole capacity utilization was 100%.
20-05-2026
NGL Fine-Chem Limited has informed the stock exchanges that its Board of Directors, scheduled to meet on May 21, 2026, will consider and recommend a final dividend for FY2025-26, in addition to approving audited financial results and fixing AGM-related dates. The trading window remains closed until May 23, 2026, per insider trading regulations.
- · Board meeting scheduled for May 21, 2026, to consider audited consolidated and standalone financial results for Q4 and FY ended March 31, 2026.
- · Board will also fix the date of the Annual General Meeting (AGM), book closure, and record date for AGM and e-voting.
- · Trading window closed from April 1, 2026, and will remain closed until 48 hours after the results declaration (May 23, 2026).
20-05-2026
Samvardhana Motherson International Limited has appointed M/s B S R & Co. LLP as its new statutory auditor for a five-year term from the 40th AGM (2027) to the 45th AGM (2032), subject to shareholder approval. The current auditor, S. R. Batliboi & Co. LLP, will continue until the 40th AGM, completing its second consecutive five-year term. The change is a routine governance update with no financial impact or performance data.
- · The Board meeting commenced at 10:00 IST and concluded at 14:20 IST on May 20, 2026.
- · B S R & Co. LLP was constituted on March 27, 1990, and converted to an LLP on October 14, 2013.
- · The firm's registered office is at 14th Floor, Central B Wing and North C Wing, Nesco IT Park 4, Nesco Centre, Western Express Highway, Goregaon (East), Mumbai-400063.
- · B S R & Co. LLP is a member entity of B S R & Affiliates, a network registered with the Institute of Chartered Accountants of India.
20-05-2026
Eris Lifesciences Limited announced its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, with an unmodified audit opinion. The Board declared an interim dividend of ₹7.21 per share (721%) for FY2026-2027, with a record date of May 29, 2026, and payment by June 19, 2026. The consolidated financials include 6 subsidiaries and a joint venture, with total assets of ₹1,283.87 Crore and total revenues of ₹545.48 Crore for the year.
- · The audit reports were submitted with unmodified opinion(s) (free from any qualifications).
- · The Board meeting commenced at 11:00 A.M. and concluded at 02:30 P.M. on May 20, 2026.
- · The interim dividend of ₹7.21 per share (721%) is for the Financial Year 2026-2027.
- · Record date for dividend eligibility is Friday, May 29, 2026; payment on or before June 19, 2026.
- · The consolidated financial results include 6 subsidiaries (total assets ₹1,283.87 Cr, total revenues ₹545.48 Cr, net profit after tax ₹115.14 Cr, total comprehensive income ₹113.44 Cr, net cash outflows ₹11.19 Cr) and a joint venture (share of net profit after tax ₹0.09 Cr).
20-05-2026
Aptech Limited's Board of Directors approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026, with an unmodified audit opinion. The Board declared an interim dividend of ₹4.5 per share (45% of face value) for FY 2025-26. Additionally, the Board approved the reclassification of Mr. Utpal Sheth from 'Promoter Group' to 'Public' category, subject to stock exchange and shareholder approvals.
- · Audited financial results for Q4 and FY ended March 31, 2026, received an unmodified opinion from statutory auditors M/s. Bansi S. Mehta & Co.
- · The Board meeting commenced at 1:30 PM and concluded at 2:15 PM on May 20, 2026.
- · Mr. Utpal Sheth's reclassification is subject to approval of stock exchanges, shareholders via postal ballot, and other regulatory approvals.
- · Mr. Utpal Sheth does not hold more than 10% of total voting rights, does not exercise control, is not involved in management, and will not be on the Board or act as KMP for 3 years from shareholder approval.
- · Mr. Utpal Sheth is not a wilful defaulter or fugitive economic offender.
20-05-2026
Grasim Industries' board approved the acquisition of a 26% equity stake in Ampin C&I Power Thirty Private Limited, a special purpose vehicle (SPV) for a captive wind-solar hybrid power project in Harihar, Karnataka. The investment is up to ₹30.60 crore in cash, aimed at meeting green energy needs, optimizing energy costs, and complying with captive power regulations. The acquisition is not a related-party transaction and is expected to be completed within 180 days of signing key agreements.
- · The SPV was incorporated on 23rd July 2025 and has its registered office in New Delhi.
- · The hybrid facility will have a total capacity of 37.95 MWp DC / 25.30 MW AC Solar and 27 MW AC Wind.
- · No governmental or regulatory approvals are required for the acquisition.
- · The acquisition is not a related-party transaction and promoter group has no interest in the SPV.
20-05-2026
Eastern Treads Ltd. reported its standalone audited financial results for Q4 and FY ended March 31, 2026, with the statutory auditors issuing an unmodified opinion. The board also appointed Mr. Karandeep Singh as an Additional Non-Executive Independent Director for a 5-year term (subject to shareholder approval) and re-appointed M/s RGN Price and Co. as internal auditors for FY 2026-27. No specific financial figures or period-over-period comparisons were provided in the filing, limiting the ability to assess performance trends.
- · The board meeting started at 12:50 PM and concluded at 2:30 PM on May 20, 2026.
- · Mr. Karandeep Singh is a Chartered Accountant (Merit Lister) and Gold Medallist in B.Com (Hons) from Delhi University.
- · Mr. Singh is not debarred from holding the office of Director by SEBI or any other authority.
- · M/s RGN Price and Co. is a national firm of chartered accountants providing audit, advisory, and assurance services.
- · The statutory auditors (G Joseph & Associates) issued an unmodified opinion on the standalone financial statements for FY ended March 31, 2026.
20-05-2026
Kandagiri Spinning Mills Ltd has announced a Board Meeting scheduled for May 30, 2026, to consider and approve the audited standalone financial results for the fourth quarter and year ended March 31, 2026. The trading window for designated persons has been closed from April 1, 2026, and will remain closed until June 1, 2026, in compliance with insider trading regulations. No financial figures or performance comparisons are provided in this notice.
- · Board Meeting date: May 30, 2026
- · Trading window closure: April 1, 2026 to June 1, 2026
- · Meeting location: Registered office in Udayapatti, Salem - 636140
- · Purpose: Consider and approve audited standalone financial results for Q4 and FY ended March 31, 2026
20-05-2026
Shriram Properties Limited has announced an earnings call scheduled for May 25, 2026, to discuss its operational and financial performance for Q4 and the full fiscal year ended March 31, 2026. The call will feature senior management including the Chairman & MD, CEO, Executive Director, and CFO. No financial results or performance data are included in this filing.
- · Earnings call is scheduled for Monday, May 25, 2026, at 4:30 PM IST.
- · Pre-registration is required via a provided link.
- · International toll-free numbers are available for Hong Kong, Singapore, UK, and USA.
- · The filing does not contain any financial figures or performance metrics.
20-05-2026
R.R.Securities Ltd. has filed a notice convening a Board Meeting on May 28, 2026, to consider and approve the audited financial results for Q4 and the full fiscal year ended March 31, 2026. The agenda includes review of compliance certificates, disclosures from directors and promoters, related party transactions, and authorization for the upcoming Annual General Meeting. No financial figures, period-over-period changes, or performance metrics are disclosed in this notice.
- · The board meeting is scheduled for May 28, 2026 at 5:00 PM at the registered office in Ahmedabad.
- · The company will consider and approve audited financial results prepared on an IND AS Stand-Alone basis for the quarter and year ended March 31, 2026.
- · Agenda includes review of auditors' report and management explanations on any observations or remarks.
- · Authorization will be sought for Mr. Rajendra Babulal Shah to fix record date, book closure, and AGM details.
- · The agenda also includes review of annual disclosures from directors, promoters, and key managerial personnel regarding shareholding and pledge status.
20-05-2026
Grasim Industries' Board approved audited standalone and consolidated financial results for FY ended March 31, 2026, and recommended a dividend of ₹10 per equity share (500% on face value of ₹2). The Board also approved the appointment of Deloitte Haskins & Sells as Joint Statutory Auditor for five years, replacing BSR & Co., subject to shareholder approval. The auditors issued an unmodified opinion on the financial results.
- · The Board meeting commenced at 12:15 PM IST and concluded at 2:31 PM IST on May 20, 2026.
- · The appointment of Deloitte Haskins & Sells as Joint Statutory Auditor is for a term of five years, from the conclusion of the 79th AGM to the conclusion of the 84th AGM.
- · KKC & Associates LLP continues as Joint Statutory Auditor.
- · The auditors' report includes an unmodified opinion on both standalone and consolidated financial results for FY 2025-26.
- · The standalone financial results include the financial statements of Grasim Employees' Trust and four joint operations (limited liability partnerships).
20-05-2026
Switching Technologies Gunther Ltd. informed BSE that its Board Meeting on May 25, 2026, will also consider the appointment of new directors, in addition to adopting audited financial results for Q4 and FY ended March 31, 2026. The company had inadvertently omitted this agenda item in its earlier intimation dated May 18, 2026.
- · The board meeting is scheduled for Monday, May 25, 2026.
- · The company had previously intimated the stock exchange on May 18, 2026, about the board meeting but missed mentioning the appointment of new directors.
- · The filing is being submitted via PDF and XBRL mode.
20-05-2026
Borosil Scientific Limited's Board approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, with an unmodified audit opinion from Chaturvedi & Shah LLP. The Board also approved a proposal to seek shareholder approval to raise up to ₹250 crore via QIP, FCCBs, or other modes, and re-appointed Mr. Vinayak Patankar as Whole-time Director & CEO for three years from December 2, 2026. However, the company experienced the resignation of Company Secretary & Compliance Officer Mr. Sanjay Gupta effective May 20, 2026, though a replacement, Mr. Ramavtar Sharma, was appointed effective May 21, 2026.
- · Audited financial statements (standalone & consolidated) for year ended March 31, 2026 received unmodified audit opinion from Chaturvedi & Shah LLP.
- · Board meeting commenced at 12:50 PM IST and concluded at 2:35 PM IST on May 20, 2026.
- · Mr. Sanjay Gupta resigned as Company Secretary & Compliance Officer effective May 20, 2026 to pursue an alternate career opportunity; no other reasons for resignation.
- · Mr. Ramavtar Sharma, a qualified Company Secretary (ACS 63784) with over 5 years experience, appointed as Company Secretary & Compliance Officer effective May 21, 2026.
- · Mr. Vinayak Patankar holds a Master of Science in Physical Chemistry and an Executive MBA in Marketing; he has over three decades of experience.
- · Mr. Ramavtar Sharma was also authorized as one of the KMPs for disclosure of material events to stock exchanges effective May 21, 2026.
- · Updated list of KMPs authorized for disclosure includes Mr. Vinayak Patankar, Mr. Somnath Billur, and Mr. Ramavtar Sharma.
20-05-2026
Man Infraconstruction Limited has scheduled an in-person Analysts/Investors Group Meeting for June 05, 2026 at its Aaradhya Avaan Site in Tardeo, Mumbai. The meeting is part of its ongoing investor outreach program and no unpublished price sensitive information will be shared.
- · The meeting is scheduled for June 05, 2026 at the Aaradhya Avaan Site in Tardeo, Mumbai
- · The meeting format is in-person, not virtual
- · The schedule may change due to exigencies on the part of analysts/investors/the company
- · No unpublished price sensitive information (UPSI) will be shared during the meet
20-05-2026
Radico Khaitan Limited has informed the exchanges that its senior management will participate in three investor conferences between May 29 and June 8, 2026: the 360 ONE Capital (B&K) 16th Annual Investor Conference (TRINITY INDIA 2026), the Nomura Investment Forum Asia (NIFA) 2026 in Singapore, and the ICICI Securities India Investor Conference 2026. The company has stated that no unpublished price sensitive information will be discussed during these meetings. The presentation to be used is available on the company's website.
- · The company will attend three investor conferences: TRINITY INDIA 2026 (May 29), Nomura Investment Forum Asia 2026 in Singapore (June 2-3), and ICICI Securities India Investor Conference 2026 (June 8).
- · The disclosure is made under Regulation 30 of SEBI Listing Regulations.
- · The presentation is available on the company's investor relations website.
Get daily alerts with 12 investment signals, 8 risk alerts, 10 opportunities and full AI analysis of all 50 filings
₹500/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: India Stock Market Daily Regulatory Digest
🇮🇳 More from India
View all →May 28, 2026
India Pre-Market Regulatory Roundup — May 28, 2026
India Pre-Market Regulatory Roundup
May 28, 2026
India Quarterly Results BSE NSE Announcements — May 28, 2026
India Quarterly Results BSE NSE Announcements
May 28, 2026
India Upcoming Corporate Actions BSE NSE — May 28, 2026
India Upcoming Corporate Actions BSE NSE
May 27, 2026
India Pre-Market Regulatory Roundup — May 27, 2026
India Pre-Market Regulatory Roundup